Erica C. VanderPorten

Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase

Peter S. Dragovich, Benjamin P. Fauber, Laura Corson et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 90 citations · Full text

Aldehyde Dehydrogenase, Human Lactate Dehydrogenase, Biochemistry +6

The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model

Erica C. VanderPorten, Pietro Taverna, Jennifer N. Hogan et al. · Molecular Cancer Therapeutics · 2009 · 83 citations · Full text

Cell Culture, Cancer Biology, Tumor Biology +18

Quantitative Determination of Protein–Ligand Affinity by Size Exclusion Chromatography Directly Coupled to High-Resolution Native Mass Spectrometry

Chengfeng Ren, Aaron O. Bailey, Erica C. VanderPorten et al. · Analytical Chemistry · 2018 · 62 citations

Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase

Benjamin P. Fauber, Peter S. Dragovich, Jinhua Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 60 citations · Full text

Medicinal Chemistry, Biochemistry, Human Lactate Dehydrogenase +6

Differential Effects of Divalent Manganese and Magnesium on the Kinase Activity of Leucine-Rich Repeat Kinase 2 (LRRK2)

Brian Lovitt, Erica C. VanderPorten, Zejuan Sheng et al. · Biochemistry · 2010 · 46 citations

Mitophagy, Cellular Physiology, Differential Effects +18